Yunda Huang

20PUBLICATIONS
114CO-AUTHORS
Nanotoxicology, health and safetyInnate immunityGenetic immunologyNanomedicineImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 28, 2026
Prophylactic treatment with broadly neutralizing antibody VRC01 selects for escape mutants after infection in Antibody-Mediated Prevention trials.

|Sep 24, 2026
Relative efficacy, safety and immunogenicity of bivalent versus monovalent COVID-19 mRNA booster vaccines: a randomized trial.

|Apr 03, 2026
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.

Carolyn Williamson, Chivonne Moodley, Craig A Magaret

|Oct 06, 2025
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV.

Nonhlanhla N Mkhize, Bo Zhang, Caroline Brackett

|Jul 05, 2025
Dose finding in early-phase human immunodeficiency virus type 1 prevention monoclonal antibody clinical trials.

Yunda Huang, Bo Zhang, Lily Zhang

|Jun 09, 2025
Pharmacokinetics Analysis of Serum and Rectal Tissue Concentrations of a Pair of Anti-HIV Monoclonal Antibodies, VRC01 and VRC01LS, in Adults Without HIV.

Yunda Huang, Lily Zhang, Maria P Lemos

Pageof 4

Frequent Collaborators

14 joint publications

Lawrence Corey

12 joint publications

Peter Gilbert

10 joint publications

Lindsay N Carpp

8 joint publications

Michal Juraska